Manhattan, NY Cushman & Wakefield has arranged a 30,000 s/f sublease on behalf of Opentrons at the Alexandria Center for Life Science, located at 430 East 29th St. This space serves as Opentrons’ first location in the area and will allow the biotechnology company to operate a Pandemic Response Lab, doubling the city’s COVID-19 testing capabilities.
A Cushman & Wakefield team of William Hartman, Michael Baraldi and James Gale represented Opentrons in the transaction.
Opentrons, a biotechnology company that creates robots for biologists, will be occupying one floor at the Alexandria Center for Life Science.
“Pandemic Response Labs have been a key aspect of NYC’s public health response to the pandemic,” said William Hartman. “We are thrilled to help the city expand its COVID-19 testing capabilities.”
“Increasing New York City’s COVID-19 testing capacity to enable faster, more easily accessible, scalable and effective testing is critical to curtailing the spread of COVID-19 as well as facilitating a safer reopening of workplaces, schools, communities and society overall,” said John Cunningham, executive vice president and regional market director of New York City at Alexandria Real Estate Equities, Inc. “We are proud that our leadership position in New York City’s life science ecosystem has provided us the opportunity to work closely with the City of New York and the NYCEDC to bring Opentrons and its Pandemic Response Lab to the Alexandria Center. This represents an important step in preparing for potential resurgences this fall.”
The biotechnology company’s mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other’s results. The company’s robots automate experiments that would otherwise be done by hand, allowing the scientific community to spend more time pursuing answers to some of the 21st century’s most important questions.